Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 6,230,000 | 5,904,000 | 6,059,000 | 5,554,000 | 5,802,000 |
| Cost of Goods | 1,096,000 | 1,037,000 | 1,024,000 | 944,000 | 1,059,000 |
| Gross Profit | 5,134,000 | 4,867,000 | 5,035,000 | 4,610,000 | 4,743,000 |
| Operating Expenses | 2,752,000 | 2,544,000 | 2,203,000 | 1,884,000 | 2,498,000 |
| Operating Income | 2,382,000 | 2,323,000 | 2,832,000 | 2,726,000 | 2,245,000 |
| Interest Expense | 352,000 | 355,000 | 347,000 | 338,000 | 332,000 |
| Other Income | 155,000 | 126,000 | 162,000 | 231,000 | 301,000 |
| Pre-tax Income | 2,185,000 | 2,094,000 | 2,647,000 | 2,619,000 | 2,214,000 |
| Income Tax | 257,000 | 235,000 | 351,000 | 308,000 | 6,478,000 |
| Net Income Continuous | 1,928,000 | 1,859,000 | 2,296,000 | 2,311,000 | -4,264,000 |
| Net Income | $1,928,000 | $1,859,000 | $2,296,000 | $2,311,000 | $-4,264,000 |
| EPS Basic Total Ops | 3.05 | 2.88 | 3.50 | 3.27 | -5.81 |
| EPS Basic Continuous Ops | 3.05 | 2.88 | 3.50 | 3.27 | -5.81 |
| EPS Diluted Total Ops | 3.03 | 2.86 | 3.48 | 3.25 | -5.77 |
| EPS Diluted Continuous Ops | 3.03 | 2.86 | 3.48 | 3.25 | -5.77 |
| EBITDA(a) | $2,872,000 | $2,824,000 | $3,316,000 | $3,197,000 | $2,694,000 |